Newsroom

Extra! Extra!
Read all about it!

Welcome to our Newsroom, your go-to source for the latest updates on Galapagos. Explore press releases, insightful blogs, and access our resource hub, complete with company materials, designed to provide media and journalists with comprehensive information about our company’s innovations and milestones

Press releasesDownload Center

The latest

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

Galapagos today announced that four abstracts, including two oral presentations on encore preliminary clinical and translational data for its seven-day vein-to-vein CAR-T product candidates GLPG5101 and GLPG5201, will be presented at the 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) to be held in Glasgow, UK, on 14-17 April 2024

Read more

The latest

Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings

Galapagos NV publishes its annual report for the financial year 2023 and announces its Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) to be held sequentially on Tuesday, 30 April 2024 at 2:00 pm (CET) and 3:00 pm (CET), respectively, at the registered office of the Company.

Read more

The latest

Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board

Galapagos NV today announced that during its meeting of 26 March 2024, the Board of Directors appointed Mr. Andrew Dickinson as Non-Executive Non-Independent Director by way of cooptation.

Read more

STORIES

Reflecting on EBMT24 with Judith: A Recap from Glasgow

Judith looks back on our presence at the EBMT 2024 congress, which took place in Glasgow, Scotland. Star Trek, a typical Glaswegian pub and decentralized manufacturing, it’s all in a day’s work. Galapagos was present with a booth, 4 abstracts and 2 oral presentations on our 2 CD19* programs. Read more in Judith’s story.
ReadAll stories

Press releases

Galapagos presents at EBMT-EHA annual meeting 2024

Showcases meaningful advances in decentralized CAR T-cell manufacturing and presents translational and clinical data from ongoing Phase 1/2 CD19 CAR-T studies Mechelen, Belgium; 15 February…
View All Press Releases

Follow our journey

Subscribe to receive our press releases

Do you want to stay up to date on our journey, as we are pioneering for patients?

Subscribe to our press releasesContact Media Relations